Tylosin is produced by Streptomyces fradiae via a combination of polyketide metabolism and synthesis of three deoxyhexose sugars, of which mycaminose is the first to be added to the polyketide aglycone, tylactone (protylonolide). Previously, disruption of the gene (tylMII) encoding attachment of mycaminose to the aglycone unexpectedly abolished accumulation of the latter, raising the possibility of a link between polyketide metabolism and deoxyhexose biosynthesis in S. fradiae. However, at that time, it was not possible to eliminate an alternative explanation, namely, that downstream effects on the expression of other genes, not involved in mycaminose metabolism, might have contributed to this phenomenon. Here, it is shown that disruption of any of the four genes (tylMI-III and tylB) specifically involved in mycaminose biosynthesis elicits a similar response, confirming that production of mycaminosyl-tylactone directly influences polyketide metabolism in S. fradiae. Under similar conditions, when mycaminose biosynthesis was specifically blocked by gene disruption, accumulation of tylactone could be restored by exogenous addition of glycosylated tylosin precursors. Moreover, certain other macrolides, not of the tylosin pathway, were also found to elicit qualitatively similar effects. Comparison of the structures of stimulatory macrolides will facilitate studies of the stimulatory mechanism.
INTRODUCTION
Tylosin, a macrolide antibiotic produced by Streptomyces fradiae, consists of a polyketide lactone substituted with three 6-deoxyhexose sugars. The TylG polyketide synthase (PKS) produces and cyclizes the aglycone (tylactone, also known as protylonolide), which is subsequently oxidized at C-20 and C-23 to generate tylonolide and concurrently substituted with three deoxyhexose sugars (-mycaminose, 6-deoxy--allose and -mycarose ; Fig. 1 ). These are added in a preferred but not obligatory order, although (importantly, in the present context) mycaminose always goes on first. Finally, the deoxyallose moiety is converted to -mycinose via stepwise bis-O-methylation, thereby generating tylosin (for a review, see Baltz & Seno, 1988) . Elucidation of the biochemical route to tylosin relied heavily on blocked S. fradiae mutants, which displayed nine distinct phenotypes in cross-feeding analysis and eventually allowed 13 genetic loci (tylA-M) to be mapped by complementation with cloned fragments of tyl DNA (Fishman et al., 1987 ; Beckmann et al., 1989) .
More recently, the entire tyl gene cluster (" 85 kb) has been sequenced (Szoke et al., 1989 ; Rosteck et al., 1991 ; Merson-Davies & Cundliffe, 1994 ; Gandecha & Cundliffe, 1996 ; Gandecha et al., 1997 ; Wilson & Cundliffe, 1998 ; Bate et al., , 2000 Fouces et al., 1999 ; Wilson & Cundliffe, 1999 ; see also GenBank accession no. U78289), revealing five mega genes (total " 41 kb) that encode the TylG PKS, flanked by sugar biosynthetic genes, ancillary genes, regulatory elements and resistance determinants (for a review, see Cundliffe, 1999 distant from their functional partner (tylB), which curiously lies on the other side of tylG (Fig. 2) . Although the tylL locus was originally mapped to the region occupied by tylMI-III (cited in Fishman et al., 1987) and although a tylL mutant was found to harbour an opal mutation in tylMII (Clark, 1997) , the TylL phenotype (i.e. failure to synthesize or add any of the three tylosin sugars) cannot readily be explained by impairment of the function of any one of the tylM genes and, therefore, probably results from multiple mutations. For that reason, the ' tylL ' locus is not represented in Fig. 2 .
The present work arises from earlier studies (Fish & Cundliffe, 1997) in which tylMII (inappropriately referred to as ' tylM2 ' at that time) was disrupted in the genome of S. fradiae. This gene (orf2* in the systematic nomenclature, see Fig. 2 ) encodes mycaminosyltransferase (Gandecha et al., 1997) , the enzyme that normally adds the first sugar during tylosin production. It was therefore expected that the tylMII-disrupted strain, SF01, would be unable to produce tylosin or any of its glycosylated precursors, but would still retain the ability to bioconvert such precursors to tylosin. Such proved to be the case but, surprisingly, strain SF01 did not accumulate tylactone, except when fed exogenously with glycosylated macrolides such as O-mycaminosyltylonolide (OMT). In contrast, when genes involved in the biosynthesis or addition of mycinose or mycarose were disrupted (Wilson & Cundliffe, 1998 ; Bate et al., 2000) , the predicted products (demycinosyl-tylosin and demycarosyl-tylosin, respectively) accumulated. Although no unequivocal explanation was offered for Control of tylactone production the results obtained with strain SF01, it seemed possible that tylactone production was somehow stimulated (mechanism unspecified) by glycosylated macrolides. As an added complication, however, impairment of polyketide metabolism in strain SF01 in the absence of glycosylated compounds might not have resulted exclusively from disruption of tylMII per se, but might have involved possible downstream effects -particularly on expression of orf4* (ccr). This gene encodes crotonyl-CoA reductase with a likely role in production of butyryl-CoA, the 4-carbon extender substrate that provides carbons 5, 6, 19 and 20 of tylactone (Gandecha et al., 1997) . The aim of the present work was to resolve this matter and to examine further the apparent influence of glycosylated macrolides on polyketide metabolism in S. fradiae.
METHODS
Bacterial strains and genetic manipulations. S. fradiae T59235 (also known as C373.1 ; referred to here as wild-type) and derivatives thereof were propagated at 30 mC in tryptic soy broth (TSB ; Difco) in sprung flasks or at 37 mC on AS-1 agar plates (Wilson & Cundliffe, 1998 ) and maintained at k70 mC as mycelial fragments following addition of DMSO (5 %, v\v; final concentration) to TSB-grown cultures. Plasmids were manipulated in Escherichia coli DH5α using standard protocols (Sambrook et al., 1989) . DNA was introduced into S. fradiae by conjugal transfer from E. coli S17-1 as described elsewhere (Fish & Cundliffe, 1997 ) using pOJ260 (Bierman et al., 1992) and pLST9828 . pOJ260 is incapable of replication in Streptomyces spp. and was used for targeted gene disruption. pLST9828, used for complementation analysis, integrates with high efficiency into the chromosomal ΦC31 attB site and contains a powerful constitutive promoter, ermEp* (Bibb et al., 1994) , for expression of inserted DNA. Both vectors carry apramycin-resistance markers.
Targeted gene disruption via gene transplacement. Fragments of tyl DNA, each containing a specific mycaminosebiosynthetic gene, were ligated into pIJ2925 (Janssen & Bibb, 1993) . Each of these DNA fragments contained a central, unique restriction site located within the cloned gene, into which the hygromycin B resistance cassette, Ωhyg (2n3 kb, with flanking transcriptional terminators ; Blondelet-Rouault et al., 1997) , was inserted via blunt-end ligation. The complete insert was then excised using BglII sites which flank the pIJ2925 polylinker and ligated into the BamHI site of pOJ260. Following conjugal transfer into S. fradiae, transconjugants were selected on hygromycin B and then screened for apramycin sensitivity (Fish & Cundliffe, 1997) to identify those in which chromosomal target genes had been replaced with disrupted constructs via double recombination. The gene disruption constructs were assembled as follows.
Disruption of tylMIII (orf1*). A 2126 bp AgeI fragment from cosmid pMOMT4 (Beckmann et al., 1989) was cloned in pIJ2925. Insertion of Ωhyg at the unique MluI site interrupted the sequence encoding TylMIII (normally 423 amino acids) 291 bp downstream of the proposed translational start.
Disruption of tylMII (orf2*). A strain disrupted in tylMII and designated SF01 was already available for analysis (Fish & Cundliffe, 1997 Disruption of tylB (orf2). A 2251 bp HincII fragment from pSET552 (Beckmann et al., 1989) was ligated into pIJ2925 and Ωhyg was inserted at a unique BstEII site, thereby disrupting the tylB coding sequence 638 bp downstream from its putative translational start. The truncated gene product was predicted to be 212 amino acids in length compared with 388 amino acid residues for the intact protein.
Authentication of disrupted strains. Southern blot hybridization analysis, using the Boehringer Mannheim DIG High Prime DNA Labelling and Detection Starter Kit II, was used to confirm each of the gene disruptions using probes specific to the respective target genes.
Complementation of disrupted strains. To compensate for possible effects on the expression of downstream genes in the tylB-disrupted strain, a 3118 bp MluI-EcoRV fragment of tyl DNA from pSET552 (together with ermEp*) was inserted into the chromosomal ΦC31 attB site using pLST9828. The complementing DNA fragment contained the co-directional genes tylAI, tylAII and tylO together with flanking sequences (139 bp upstream of tylAI and 144 bp downstream of tylO) and was oriented favourably for control by ermEp*.
Tylosin production fermentation and metabolite analysis.
Fermentation and HPLC analysis of the products was carried out as described elsewhere except that, for convenience, 0n5% (w\v) corn steep solids (Sigma) replaced 1n0% (v\v) corn steep liquor in pre-fermentation media used for some later fermentations. Control experiments revealed no detectable impact of this change on extracted fermentation products. In bioconversion studies, tylosin precursors or other macrolides (10 mg each, dissolved in 100 µl DMSO) were added to fermentations (50 ml cultures) after 2 d and incubation was continued for a further 5 d before analysis. DMSO was added to control fermentations.
RESULTS AND DISCUSSION

Disruption of ccr (orf4*)
This was achieved via targeted gene replacement (involving double recombination) using the hygromycin B resistance cassette, Ωhyg (Blondelet-Rouault et al., 1997) . Having confirmed the disruption (' knockout ') by Southern analysis, the resultant ' ccr-KO ' strain was fermented and the products were examined by HPLC (Fig. 3) . Since the disrupted strain still produced significant, although reduced, amounts of tylosin, the ccr gene product was evidently not essential for tylosin production under these conditions. Interestingly, the ccr-specific probe that was used to confirm the authenticity of the knockout strain also found a second hybridization target at high stringency (presumably, another ccr gene) elsewhere in the S. fradiae genome. We do not know whether any requirement for Ccr activity during tylosin production under these conditions can be satisfied (partially or otherwise) by the product of the ' other ' gene but, in any event, impaired expression of orf4* could not have accounted for the failure of strain SF01 to accumulate tylactone in earlier studies.
Disruption of mycaminose-biosynthetic genes
Targeted gene replacement, again using Ωhyg, was employed to disrupt (separately) tylMI, tylMIII and tylB in the genome of S. fradiae and the respective disruptions were confirmed by hybridization analysis using probes specific to each of the target genes (data not shown). The latter have been proposed (see Cundliffe, 1999) to encode methyltransferase (product of tylMI), putative 3,4-isomerase (product of tylMIII) and aminotransferase (TylB) activities, which, together with mycaminosyltransferase (encoded by tylMII), constitute the entire complement of enzymes specifically required for the biosynthesis and addition of mycaminose during tylosin production (Fig. 4) . When fermentation products from the three disrupted strains (designated tylMI-KO, tylMIII-KO and tylB-KO) were analysed by HPLC, the results were similar and resembled those previously observed with strain SF01 (tylMII-KO). None of these strains produced tylosin (confirming for the first time that orf1* is indeed a 'tyl ' gene), nor did they accumulate tylactone unless a glycosylated macrolide (here, OMT) Control of tylactone production was added exogenously to the fermentation medium. Only data obtained with the tylB-KO strain are shown here (Fig. 5) . Again, it was necessary to control for possible downstream effects resulting from disruption of the target gene. Thus, tylAI and tylAII (inappropriately designated tylA1 and tylA2 earlier ; Merson-Davies & Cundliffe, 1994) lie immediately downstream of tylB ( Fig. 2) and encode enzymes common to the biosynthesis of all three tylosin sugars (Fig. 4) . Also, and more importantly in the present context, tylO encodes an ' editing ' thioesterase that greatly affects the level of tylactone production . However, when a DNA fragment containing [tylAI-tylAII-tylO] under control of the strong constitutive promoter ermEp* was integrated into the genome of the tylB-KO strain, the resultant organism remained unable to accumulate tylactone except in the presence of exogenous OMT (Fig. 5b, c) . Under the latter conditions, the added OMT was converted to desmycosin (demycarosyl-tylosin) and not to tylosin. This was not unexpected since orf6 (downstream of, and co-directional with, tylB) had previously been characterized as a mycarose-biosynthetic gene, i.e. tylCVI (Bate et al., 2000) . Evidently, orf2 (tylB) and orf6 (tylCVI) are normally co-transcribed.
Two conclusions follow from these data. Firstly, failure of these various disrupted strains to accumulate tylactone was a direct consequence of the impairment of mycaminose biosynthesis and did not result indirectly from effects on the expression of genes downstream of the respective knockout targets. Secondly, tylosin precursors such as OMT (and, to a lesser extent, tylosin itself ; see Fish & Cundliffe, 1997 ) exert a positive influence on tylactone production in the various knockout strains. Presumably, in wild-type S. fradiae, tylactone biosynthesis proceeds at only minimal levels unless the product gets glycosylated, in which case a trickle becomes a flood.
Effects of macrolides other than tylosin precursors
It was argued previously (Fish & Cundliffe, 1997 ) that accumulation of tylactone in strain SF01 after feeding with OMT could not be due to degradation of OMT, since cleavage of the latter would release tylonolidenot tylactone. This point was reinforced in the present work when tylactone accumulation in the tylMIIdisrupted strain, SF01, was triggered by OMT at inputs too low to be detected by HPLC following re-extraction from fermentation cultures (data not shown). It was also observed that accumulation of tylactone in this strain could be provoked, albeit with differing efficiencies, by glycosylated macrolides other than tylosin precursors, including rosaramicin and spiramycin, but not by chalcomycin, erythromycin or carbomycin (Fig. 6 ). Although these data do not reveal the structural features needed to elicit this effect, it is clear that the accumulated tylactone could not have been derived from the added compounds.
Summary and conclusions
The present data establish that tylactone biosynthesis in S. fradiae is controlled by glycosylated macrolides, although it is not clear whether stimulation of polyketide metabolism by OMT, etc. involves activation or derepression of tylG expression. In other work, tylactone production was shown to require expression of the regulatory gene tylR, disruption of which prevented S. fradiae from accumulating tylactone even in the presence of exogenously added OMT . Since tylR appears to encode a positive regulator, it is possible that efficient transcription of tylG requires the TylR protein together with glycosylated macrolides as cofactors. Moreover, expression of tylR is also needed for deoxyhexose metabolism (and, in particular, for mycaminose biosynthesis) in S. fradiae, since tylactone was not glycosylated when fed exogenously to a tylRdisrupted strain . These data could be reconciled if TylR were to regulate the synthesis of mycaminose (and the other tylosin sugars ?) in concert with tylactone production, in which case it would be instructive to know whether OMT also influences deoxyhexose metabolism in S. fradiae, perhaps by binding to TylR.
In conclusion, the manner in which glycosylated macrolides stimulate tylactone production in S. fradiae
is not yet understood. Future studies will centre on the (presumed) DNA-binding properties of the TylR protein and on attempts to identify OMT-binding regulatory protein(s).
